Renal Cancer - Results from #960

Comparison between minimally-invasive partial nephrectomy and open partial nephrectomy for complex renal tumors: A systematic review and meta-analysis. April 26, 2023

Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma. April 26, 2023

Impact of Therapy Management on Axitinib-Related Adverse Events in Patients With Advanced Renal Cell Carcinoma Receiving First-Line Axitinib + Checkpoint Inhibitor. April 25, 2023

Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma. April 25, 2023

Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. April 24, 2023

Clear cell renal cell carcinoma molecular variations in non-Hispanic White and Hispanic patients. April 24, 2023

Volumetric Quantitative Contrast-enhanced Ultrasonography Evaluation of Complex Renal Cysts: An Adjunctive Metric to the Bosniak Classification System to Predict Malignancy. April 24, 2023

Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism. April 21, 2023

Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions. April 21, 2023

Update on combined immunotherapy for the treatment of advanced renal cell carcinoma. April 20, 2023

Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification. April 20, 2023

PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma. April 20, 2023

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC). April 19, 2023

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. April 19, 2023

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1). April 18, 2023

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Small Renal Cell Carcinomas after Image-Guided Cryoablation or Radio-Frequency Ablation. April 18, 2023

Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma. April 17, 2023

Critical Evaluation of a microRNA-Based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava. April 17, 2023

BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials. April 14, 2023

Identifying the Needs of Health Care Providers in Advanced First-Line Renal Cell Carcinoma: A Mixed-Methods Research. April 14, 2023

Page 49 of 456